Effects of non-pharmacological interventions on body composition and physical function in older women with sarcopenic obesity: a meta-analysis.

Background: Sarcopenic obesity is characterized by excessive fat mass accompanied by sarcopenia, resulting in combined health risks associated with both conditions. Currently, no standardized or effective treatment approach has been established. The health risks and potential for physical disability associated with sarcopenia increase with age, and older women face greater challenges than men due to the accelerated muscle loss following menopause. Objective: Given the absence of standardized or effective treatments, this systematic review aimed to evaluate which non-pharmacological interventions can effectively improve body composition and physical function in older women (aged ≥60 years) with sarcopenic obesity. Design: Systematic review and meta-analysis. Setting and participants: Older women aged 60 years and above. Methods: A comprehensive search of four electronic databases (PubMed, Web of Science, Embase, and the Cochrane Library) was conducted up to April 2025. A total of 11 studies were included in the meta-analysis, comprising 10 randomized controlled trials (RCTs) and one quasi-experimental study. Although the latter did not employ random allocation, it was included due to the rigor of its intervention design, the completeness of its data, and its relevance to the research question. The primary outcomes measured included key indicators of body composition and physical function. The methodological quality of the included studies was assessed using the Cochrane Risk of Bias 2.0 (RoB 2) tool. To determine the certainty of evidence for the main outcomes, the GRADE approach was applied, evaluating five domains: risk of bias, inconsistency, indirectness, imprecision, and publication bias. Results: A total of 11 studies (10 randomized controlled trials and 1 non-randomized controlled trial) involving 532 participants were included. Meta-analysis revealed that exercise and other non-pharmacological interventions significantly reduced body fat percentage (WMD = -1.85, 95% CI: -3.35 to -0.36, Conclusion: Future studies on sarcopenic obesity should adopt the latest international consensus criteria (e.g., European Working Group on Sarcopenia in Older People 2, Asian Working Group for Sarcopenia 2019) to enhance the comparability and clinical applicability of findings. Current evidence indicates that exercise interventions, particularly resistance training, serve as the cornerstone for improving handgrip strength and functional outcomes such as gait speed. Various non-pharmacological approaches have also been validated in improving body composition indicators (Body Fat Percentage, Appendicular Free Fat Mass, and Skeletal Muscle Index). The synergistic effects of combined exercise and nutritional interventions on muscle mass and strength warrant further investigation, especially to determine the optimal modality and dosage in women with sarcopenic obesity. Future intervention strategies should be systematically designed to integrate short-term intensive programs with long-term maintenance, thereby maximizing therapeutic benefits and improving clinical feasibility.